Inactive Instrument

Other languages Aerie Pharmaceuticals, Inc.

Equities

Bourse Zurich: les indices finissent de peu dans le rouge	22-11-22
Alcon : l'acquisition d'Aerie Pharmaceuticals est bouclée	22-11-22
Bourse Zurich: détente sensible à l'approche de la mi-journée	22-11-22
Morning Briefing - Markt Schweiz	22-11-22
Alcon: conclusa acquisizione Aerie Pharmaceuticals	22-11-22
Alcon schliesst Kauf von Aerie Pharmaceuticals ab	22-11-22
Alcon finalise le rachat de l'américain Aerie Pharmaceuticals	22-11-22
Alcon Concludes $930 Million Purchase of US-based Aerie Pharmaceuticals	22-11-22
Aerie Pharmaceuticals, Inc. Announces Executive Changes	22-11-21
Aerie Pharmaceuticals, Inc. Announces Management Changes	22-11-21
Alcon Research, Ltd. completed the acquisition of Aerie Pharmaceuticals, Inc. from a group of shareholders.	22-11-20
Alcon senkt Umsatz-Prognose für 2022 erneut leicht	22-11-15
Prévisions Alcon: recettes de 2,1 milliards de dollars au 3e trimestre	22-11-15
Aerie Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-03
Aktien Schweiz Schluss: SMI knackt wieder Marke von 11'000 Punkten	22-08-24
MÄRKTE USA/Rezessions- und Zinssorgen verhindern Erholung	22-08-23
Sector Update: Health Care Stocks Declining in Late Trade	22-08-23
Alcon to Acquire Aerie Pharmaceuticals in $770 Million Deal	22-08-23
Sector Update: Health Care Stocks Dropping in Afternoon Trade	22-08-23
MÄRKTE USA/Schwache Daten wecken Hoffnung auf zurückhaltendere Fed	22-08-23

No results for this search